Clinical Documents

To edit the draft, click on the text box below.

×

Draft a comprehensive differential diagnosis for acute substernal chest pain in a 45-year-old male with hypertension and hyperlipidemia, diaphoresis, exertional onset, and normal initial ECG/troponin; include life-threatening causes first, key distinguishing features, and immediate diagnostic next steps.

Draft a detailed differential diagnosis for new-onset unilateral throbbing headache with visual aura and brief monocular vision loss in a 32-year-old female on oral contraceptives; include red-flag symptoms, stroke/TIA considerations, and recommended initial workup.

Draft an assessment and plan for stage-2 hypertension (BP 162/98) in an obese 52-year-old with suspected obstructive sleep apnea; include ASCVD risk estimate, lifestyle prescriptions, first-line pharmacotherapy with drug/dose/targets, baseline labs/monitoring, and 4–6 week follow-up.

Draft an assessment and plan for type 2 diabetes follow-up with A1c 9.2% on metformin 1,000 mg BID and eGFR 65; compare adding a GLP-1 receptor agonist vs an SGLT2 inhibitor, address weight loss goals, hypoglycemia education, vaccinations, and micro/macrovascular screening.

Draft a history and physical for a patient presenting with chest pain, including HPI using OLDCARTS, pertinent ROS, PMH/meds/allergies, FH/SH, focused cardiac/pulmonary exam, initial labs and imaging orders, prioritized differential, HEART score risk stratification, and early management.

Draft a history and physical for a new patient with progressive exertional dyspnea, orthopnea, and bilateral leg edema; include differential (heart failure, COPD, PE, anemia, renal disease), targeted exam maneuvers, and first-line diagnostics and management.

Draft a progress note for COPD follow-up two weeks after an acute exacerbation treated with prednisone and antibiotics; include symptom trajectory, CAT score (if available), inhaler technique/adherence, oxygen needs, spirometry plan, smoking cessation counseling, and return precautions.

Draft a progress note for post-operative day 2 after total knee arthroplasty; include pain control strategy, DVT prophylaxis, PT/OT milestones, wound status, bowel/urinary function, labs/vitals review, complications screening, and discharge readiness.

Draft a discharge summary for community-acquired pneumonia admission; include admission/discharge dates, presenting symptoms, radiology/labs, pathogen if identified, inpatient therapies and response, discharge medications with durations, pending tests, follow-up appointments, and return precautions.

Draft a discharge summary for myocardial infarction managed with PCI and drug-eluting stent placement; include cath findings, complications, inpatient course, discharge medications (DAPT, statin, beta-blocker, ACEi/ARB), cardiac rehab referral, and follow-up plan.

Draft discharge instructions for a patient hospitalized with acute decompensated heart failure; include daily weights, sodium and fluid restriction amounts, medication list with dosing, signs of worsening heart failure, follow-up appointments, and lab monitoring plan.

Draft discharge instructions for an asthma exacerbation; include controller and reliever regimen, steroid taper schedule, spacer technique, trigger avoidance, a written asthma action plan, return precautions, and follow-up timing.

Draft a patient handout on managing high blood pressure in plain language; explain what BP numbers mean, key lifestyle steps (DASH diet, sodium limits, alcohol moderation), home BP monitoring instructions, medication adherence tips, and when to call the doctor.

Draft a patient handout for type 2 diabetes education in plain language; cover A1c goals, the plate method, physical activity targets, self-monitoring of blood glucose, hypoglycemia signs and the 15-15 rule, foot care basics, and a vaccination checklist.

Draft a summary of the latest CDC and WHO guidelines for managing community-acquired pneumonia in adults, including empiric antibiotic choices, duration of therapy, and follow-up recommendations.

Draft a plain-language overview of the ADA and AACE guidelines for diabetes management, focusing on A1c goals, weight management, and the use of GLP-1 receptor agonists and SGLT2 inhibitors.

Draft a summary of the 2024 USPSTF breast cancer screening recommendations, including updated screening intervals, risk-based approaches, and the role of MRI for high-risk patients.

Draft a concise summary of NCCN guidelines for melanoma management, including staging, surgical margins, adjuvant therapy, and checkpoint inhibitor recommendations.

Draft treatment alternatives for community-acquired MRSA skin infections in patients allergic to sulfa drugs; include oral and IV options, dosing, and duration.

Draft treatment alternatives for patients with type 2 diabetes who are unable to tolerate GLP-1 receptor agonists due to nausea; include medication substitutions and lifestyle recommendations.

Draft a summary of options for treating refractory depression, comparing ketamine infusions, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT).

Draft treatment options for advanced prostate cancer, including hormonal therapy, radiopharmaceuticals, and novel androgen receptor pathway inhibitors.

Draft a summary of recent research on mRNA vaccine technology beyond COVID-19, including applications in oncology and autoimmune disease prevention.

Draft an easy-to-understand overview of long COVID research, summarizing major symptoms, hypothesized mechanisms, and emerging treatment approaches.

Draft a summary of current research on Alzheimer’s disease biomarkers, including amyloid and tau imaging, and discuss how they influence diagnosis and trial design.

Draft an explanation of the interaction between warfarin and antibiotics such as ciprofloxacin or TMP-SMX, including INR effects and management recommendations.

Draft a summary evaluating drug interactions for patients taking Paxlovid and common cardiovascular drugs; include mechanism and recommended dose adjustments.

Draft a summary of the common and serious side effects of semaglutide, including GI intolerance, gallbladder disease, and thyroid-related warnings.

Draft an overview of potential side effects associated with long-term corticosteroid use, including osteoporosis, glucose intolerance, and adrenal suppression.

Draft a summary of essential lab tests to order in suspected acute pancreatitis, including amylase, lipase, liver enzymes, and metabolic panels, with interpretation guidance.

Draft laboratory workup recommendations for suspected hypothyroidism, including TSH, free T4, thyroid antibodies, and when to consider secondary causes.

Draft an explanation of which labs should be monitored in patients receiving methotrexate therapy, including CBC, LFTs, renal function, and frequency of monitoring.

why choose us

Edit Geo

×

300×250 Ad Slot

Research Article: Clinical outcomes of three treatment methods for humeral shaft fractures: a comparative study

Date Published: 2026-03-13

Abstract:
To compare the clinical efficacy of three techniques (nonoperation, external fixation, and open reduction and plate osteosynthesis) for the treatment of diaphyseal fractures of the humerus, thereby providing guidance for the selection of treatment methods. A retrospective analysis was conducted on 138 patients with humeral shaft fractures who received treatment at the Department of Orthopedics and Traumatology, Hubei Provincial Hospital of Traditional Chinese Medicine between January 2021 and December 2024, all with complete follow-up data. The patients were divided into three groups based on their treatment methods: the nonoperative treatment (NOT) group, the external fixation (EF) group, and the open reduction and plate osteosynthesis (ORPO) group. In the NOT group, 46 patients received small splint fixation/plaster/functional bracing. There were 28 patients in the EF group and 64 patients in the ORPO group. The patients were followed up regularly at outpatient appointments or by telephone. The follow-up evaluations included measurements of fracture-healing time, fracture-healing rate, postoperative complications, length of hospital stay, and time to return to work after treatment. Furthermore, the clinical outcomes included the Constant shoulder score, the Mayo elbow score, and patient satisfaction at the last follow-up. The mean follow-up durations for the NOT, EF, and ORPO groups were 21.4?±?3.7, 20.1?±?4.7, and 22.6?±?5.4 months, respectively. The mean union times for the NOT, EF, and ORPO groups were 9.0 (8.0–11.25) months, 10.0 (9.0–12.0) months, and 12.0 (10.25–12.0) months, respectively; additionally, the mean union rates were 95.7%, 96.4%, and 96.9%, respectively. There were significant differences in union time among the three groups ( P =?0.002, ? 2 =?0.079), but the magnitude of the difference was limited. The main complications were significantly different among the three groups ( P <?0.001, V?=?.438). Residual deformity/malunion was the main complication in the NOT group, while postoperative radial nerve palsy and infection were the main complications in the EF and ORPO groups, respectively. The length of hospital stay for the three groups was 4.0 (2.0–5.25) days, 10.5 (5.0–12.0) days, and 11.0 (8.0–15.0) days, respectively. The time to return to work after treatment for the three groups was 13.0 (10.0–16.0) weeks, 16.0 (14.25–18.75) weeks, and 14.0 (10.0–17.0) weeks, respectively. The mean duration of hospital stay and number of days away from work were significantly lower in the NOT group than in the other two groups ( P < 0.05 ), Although the hospitalization time in the EF group was shorter than that in the ORPO group, the time from treatment to return to work was longer, with both differences being statistically significant ( P <?0.05). At the last follow-up, the postoperative Constant scores and Mayo scores were not significantly different among the three groups ( P > 0.05 ). Patient satisfaction also differed significantly among groups, with higher satisfaction in the NOT group than in the EF and ORPO groups ( P <?0.05, ? 2 =?.046), although the effect size was small. Within the limitations of this retrospective, non-randomized study, our findings suggest that all three treatment modalities achieve comparable fracture union rates and functional outcomes in humeral shaft fractures. Meanwhile, these results underscore the value of individualized treatment selection. In appropriately selected patients, NOT remains a viable and cost-effective option. But these findings should be validated in prospective trials.

Introduction:
Humeral shaft fracture is a common type of fracture in clinical practice that occurs from 2?cm below the surgical neck of the humerus to 2?cm supracondylar. Humeral shaft fractures account for 1%–5% of all body fractures and approximately 20% ( 1 , 2 ) of humeral fractures. The incidence of fractures is highest among young men (21?30 years old) and elderly women (60?80 years old) ( 3 ). Owing to rapid industrialization in China and the gradual ageing of society, the incidence of humeral shaft fractures has…

Read more

300×250 Ad Slot

×
Chat & Ask Questions Career Openings Medical Doctors Check on Drug
Interactions Latest Health News
by WebHealthNetwork Get CME Credits Latest Clinical Trials Latest Research Articles Clinical Documents Update Profile

News

Chat

HCP Tools

Careers

Update Profile